New research suggests that a diet rich in vegetables, when combined with probiotics, could potentially slow the progression ...

The Alliance for Clinical Trials in Oncology has launched a randomized phase III clinical trial called RECIPROCAL (Alliance ...

A drug used to treat type 2 diabetes may also be effective in slowing the progression of prostate cancer. This is shown by an international study in which researchers at Umeå University, Sweden, have ...

A recent breakthrough study highlights how a simple at-home urine test could accurately detect prostate cancer. Researchers from Vanderbilt University and the University of Michigan suggest this ...

November 18, 2008 (Washington, DC) — The use of aspirin and other nonsteroidal anti-inflammatory drugs (NSAIDs) is significantly associated with lower levels of prostate-specific antigen (PSA).

A type 2 diabetes drug, pioglitazone, may reduce the risk of prostate cancer relapse by targeting the PPARγ protein Prostate cancer patients with diabetes on PPARγ drugs had no relapse during ...

Combining an existing small-molecule protein therapy called tumor necrosis factor related apoptosis-inducing ligand (TRAIL) with focused ultrasound (FUS) can significantly reduce tumor size and burden ...

Akron, April 05, 2025 (GLOBE NEWSWIRE) -- ProstaVive is re-inventing men's health, particularly prostate wellness. As men increasingly seek effective and natural solutions for maintaining their health ...